BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//REMEDi4ALL - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:REMEDi4ALL
X-ORIGINAL-URL:https://remedi4all.org
X-WR-CALDESC:Events for REMEDi4ALL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250731T163000
DTEND;TZID=Europe/Amsterdam:20250731T173000
DTSTAMP:20250721T084539Z
CREATED:20250721T084522Z
LAST-MODIFIED:20250721T084539Z
UID:14110-1753979400-1753983000@remedi4all.org
SUMMARY:Webinar: Cures Within Reach new funding call: Clinical trials to validate AI-driven drug repurposing
DESCRIPTION:Artificial intelligence (AI) is increasingly seen as a powerful tool in the search for new treatments – especially through drug repurposing. By analysing large sets of data\, AI can help identify existing medicines that might work for different conditions – something particularly valuable in rare diseases. \nHowever\, do AI-generated predictions actually work when tested in real-life clinical trials? \nCures Within Reach is helping to explore this question through a new funding call. They’re inviting letters of intent for Phase I/IIA clinical trials that will test and validate AI-based repurposing ideas\, with a preference for rare disease. \nLearn more about the call here. \n\n\n\n\nThis webinar hosted by Beacon for Rare Diseases in collaboration with REMEDi4ALL and Cures within Reach will cover: \n\nA breakdown of what this funding call is about\nAdvice from Cures Within Reach on what makes a strong application\nHow patient groups can get involved in applications\nA practical example of a patient group contributing to an AI-led initiative\nThe opportunity to ask any questions you might have to the Cures Within Reach team\n\n\n\n\nRegister for the webinar here!
URL:https://remedi4all.org/event/cures-within-reach-new-funding-call-clinical-trials-to-validate-ai-driven-drug-repurposing/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/07/Image20250718102044-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20251006T140000
DTEND;TZID=Europe/Amsterdam:20251010T170000
DTSTAMP:20250811T092029Z
CREATED:20250415T104016Z
LAST-MODIFIED:20250811T092029Z
UID:11711-1759759200-1760115600@remedi4all.org
SUMMARY:2025 REMEDi4ALL Hackathon
DESCRIPTION:Are you an early career researcher (ECR) who wants to delve into drug repurposing?\n  \nJoin us for the second REMEDi4ALL Hackathon\, 6-10 October 2025\, held at Hotel Checkin Montserrat\, near Barcelona\, Spain. \nThe REMEDi4ALL Repurposing Hackathon is designed to help early career researchers learn by doing. Join a small team of international trainees keen to learn about the repurposing pathway on a week-long residential course where you aim to plan the development of a repurposing candidate for a specific patient community.  \nWho is the Hackathon for?\n\nStudents and researchers in the early stages of their career up to 2 years post-doc\nIndividuals with an interest in drug repurposing\nIndividuals with an excellent scientific track record\nPrevious experience in the drug repurposing field will be considered a plus\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat will you learn?\nThe REMEDi4ALL Hackathon aims to teach participants how to: \n\nUse computational tools to generate repurposing candidates suitable for a defined indication\nNarrow down potential repurposed drug options tailored to a particular indication\nIdentify needs and knowledge gaps in a repurposing project\, helping to define the path for a drug candidate\nWork together with other ECRs to complete a repurposing challenge\n\n\n  \n\nTraining format\n\n\n\nIn-person\, residential training for 15 participants\nAdvance registration required\nSmall teams of early career researchers work on a project throughout the week\nSupport through lectures and guidance of REMEDi4ALL experts\, and external advisers\, including patient experts\n\n\n\n\n\n  \nInterested in learning more? Check out our highlights video from 2024 or explore the Hackathon website within the REMEDi4ALL Repurposing Academy.
URL:https://remedi4all.org/event/2025-remedi4all-hackathon/
LOCATION:Hotel Checkin Montserrat\, Carrer Querol\, 08293 Collbató\, Barcelona\, Spain
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20251121T140000
DTEND;TZID=Europe/Amsterdam:20251121T153000
DTSTAMP:20250915T161006Z
CREATED:20250915T161006Z
LAST-MODIFIED:20250915T161006Z
UID:15186-1763733600-1763739000@remedi4all.org
SUMMARY:Webinar: IP Strategies for Repurposing
DESCRIPTION:Discover the value of having an intellectual property (IP) strategy in your repurposing project and how to use this to drive success! \nNot sure where to start with intellectual property (IP) in your drug repurposing project? REMEDi4ALL’s Repurposing Academy is here to guide you! \nJoin us for our upcoming webinar where we will explore the importance of considering IP as part of your broader drug repurposing strategy. \nWe’ll discuss common challenges you may encounter and key considerations to keep in mind throughout your repurposing project. Additionally\, we’ll outline practical steps for securing IP protection for repurposed drugs and show how a strong IP strategy can help drive your project forward.
URL:https://remedi4all.org/event/webinar-ip-for-repurposing/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/09/CT-Webinar-Series-Webinar-1-FINAL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20251127T130000
DTEND;TZID=Europe/Amsterdam:20251127T140000
DTSTAMP:20251127T103945Z
CREATED:20251113T085710Z
LAST-MODIFIED:20251127T103945Z
UID:16671-1764248400-1764252000@remedi4all.org
SUMMARY:ProvenConnect REMEDi4ALL Webinar
DESCRIPTION:* This is an online event that will take place 1200–1300 UK time (1300-1400 CET) on Zoom. * \nREMEDi4ALL is presenting to the TAR Network in a Proven Connect webinar. Speakers Alicia Soler (Lead Scientific Operations at REMEDi4ALL /EATRIS)\, Heleen van der Meer (Senior programme manager international drug repurposing at ZonMw) and Pan Pantziarka (Director of Drug Repurposing at Anticancer Fund) will present the REMEDi4ALL project and Funder’s Network.
URL:https://remedi4all.org/event/provenconnect-remedi4all-webinar/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/11/REMEDi4ALL-funders-network-Post-para-LinkedIn-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260311T080000
DTEND;TZID=Europe/London:20260312T170000
DTSTAMP:20260217T133321Z
CREATED:20251218T141507Z
LAST-MODIFIED:20260217T133321Z
UID:17132-1773216000-1773334800@remedi4all.org
SUMMARY:REMEDi4ALL Drug Repurposing Bootcamp for Academics 2026
DESCRIPTION:From Hypothesis to Impact: Navigating the Repurposing Pathway\nDrug repurposing represents a vital pathway for treatment development\, both for patient communities and academic innovators. Finding new uses for existing drugs can provide a more rapid pathway to patient impact\, both by reducing the number of steps to a clinical trial and reducing the financial barrier to research. \nWhile the potential of repurposing is huge\, the pathway to deliver a repurposed medicine from concept to market remains a hugely challenging one. This is particularly hard for academic researchers to navigate – employing their scientific skill set to the complex and highly regulated world of drug development unsupported can lead to projects quickly becoming mired in challenges or uncertainty. \nThe REMEDi4ALL Drug Repurposing Bootcamp for Academics\, held at the Wellcome Genome Campus in Cambridge\, aims to support researchers embarking on this journey. This pilot training course will provide face to face training to explain the full drug repurposing pathway\, helping researchers understand the steps involved in turning a repurposing hypothesis into a product capable of delivering real impact to patients.
URL:https://remedi4all.org/event/remedi4all-drug-repurposing-bootcamp-for-academics-2026-2/
LOCATION:Hinxton Hall\, Wellcome Genome Campus\, Hinxton\, Cambridge\, CB10 1RQ\, United Kingdom
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/11/R4ALL-academic-bootcamp-2026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260512
DTSTAMP:20260709T073305Z
CREATED:20251114T114854Z
LAST-MODIFIED:20260709T073305Z
UID:16685-1778457600-1778543999@remedi4all.org
SUMMARY:REMEDi4ALL Funders Network Meets Policy
DESCRIPTION:REMEDi4ALL Funders Network Meets Policy\n  \nEvent Summary\nThis event has already taken place. Thank you to everyone who attended the Funders Network meeting. Read the event summary to learn more about the discussions and key takeaways. \n  \nEvent Description\nAs in previous editions\, #iDR26 will feature a pre-conference meeting dedicated to the Funders Network on Monday 11 May.  \nThis interactive workshop will bring together research funders and policy-makers to explore opportunities on coordinated funding models and co-funding practices with policy considerations around reimbursement and market access\, creating an end-to-end perspective.  \nAgenda:  \n\n12.30-13.30: Lunch \n13.30-15.30: Session 1: Push mechanisms (Funders Network & innovative funding models) \n15.30-16.00: Break \n16.00-18.00: Session 2: Pull mechanisms (Regulatory and pricing & reimbursement policy)  \n16.00-18.00: Networking drinks  \n\nAim of the Session  \n\nConvene research funders and policy representatives to build shared understanding and alignment.  \nIdentify actions funders can take to push drug repurposing forward.  \nIdentify pull mechanisms that policymakers can implement (e.g.\, incentives for industry\, regulatory levers).  \n\n Please note that this is an invitation-only event.   \nAre you a funder who is not yet a member but interested in joining? Contact us at remedi4all@zonmw.nl.  \n  \n 
URL:https://remedi4all.org/event/remedi4all-funders-network-event-2026/
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/11/iDR26-Promo-Marketplace-Meeting-061125-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260512
DTEND;VALUE=DATE:20260514
DTSTAMP:20251023T130710Z
CREATED:20251023T130544Z
LAST-MODIFIED:20251023T130710Z
UID:16315-1778544000-1778716799@remedi4all.org
SUMMARY:International Drug Repurposing Conference 2026 - #iDR26
DESCRIPTION:Join iDR26\, the International Drug Repurposing Conference\, on 12-13 May 2026 in Brussels\, Belgium to explore the future of patient-centric medicines repurposing.   \nFrom rare diseases and AI-driven drug discovery\, to policy\, funding and community-led success stories\, iDR26 brings together the global drug repurposing community to navigate the next chapter in maximising patient benefit. \nExplore the full conference here!
URL:https://remedi4all.org/event/idr26/
LOCATION:Maison de la Poste\, Brussels\, Belgium\, Rue Picard 7\, Brussels\, Belgium
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2025/10/iDR26_Promo_20251001b-1-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20260630T103000
DTEND;TZID=Europe/Amsterdam:20260630T123000
DTSTAMP:20260622T145259Z
CREATED:20260622T145259Z
LAST-MODIFIED:20260622T145259Z
UID:19454-1782815400-1782822600@remedi4all.org
SUMMARY:BioMed21 Webinar: Rare Disease Research and Drug Development with NAMs in the EU
DESCRIPTION:Exploring human-relevant in vitro and in silico approaches for disease modelling and therapeutic innovation \nWebinar description \nBioMed21 (Biomedical Research for the 21st Century Collaboration) invites you to a 60-minute webinar exploring how New Approach Methodologies (NAMs)\, including advanced human-relevant in vitro models and in silico technologies\, are transforming rare disease research and drug development. \nThe webinar will bring together experts from academia\, policy\, and biomedical research to discuss innovative approaches ranging from retinal organoids and retina-on-chip systems to computational modelling and AI-driven strategies for therapy development. \nTopics will include: \n\nHuman-centric strategies for rare disease research\nhiPSC-derived organoids and organ-on-chip technologies\nIn silico modelling and computational approaches\nTranslational opportunities and challenges for NAMs in therapy development\nEuropean research and policy perspectives\n\nDraft agenda \n\nAdvancing Human-Centric Strategies for Rare Disease Research: A European Research Policy Perspective\nFrancesca Pistollato – Humane World for Animals\nHuman retinal organoids and retina-chip platform for modeling disease and gene therapy\nKevin Achberger – University of Tübingen\nHuman-Centric In Silico Modeling for Rare Disease Research and Drug Development\nFrancesco Pappalardo – University of Catania & the COMBINE Group\nNAMs in Rare Disease Therapy Development: Where and When Do They Fit?\nManoe Janssen – Radboudumc\n\n📄 BioMed21 Policy Paper: https://biomed21.org/wp-content/uploads/2026/05/RareDiseases_WhitePaper_2026-final.pdf \n\n\n\nRegister for the webinar here!
URL:https://remedi4all.org/event/biomed21-webinar-rare-disease-research-and-drug-development-with-nams-in-the-eu/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2026/06/Diseno-sin-titulo-e1781530718337.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20260716T110000
DTEND;TZID=Europe/Amsterdam:20260716T123000
DTSTAMP:20260612T075224Z
CREATED:20260612T075106Z
LAST-MODIFIED:20260612T075224Z
UID:19370-1784199600-1784205000@remedi4all.org
SUMMARY:Webinar: Understanding the Value of your Repurposed Medicine
DESCRIPTION:An introduction to HTA\, Early HTA\, and patient preference evidence for demonstrating the value of repurposed medicines. \n\n\n\n\nRepurposing has the potential to bring treatments to patients more quickly and efficiently. However\, the success of a repurposed medicine depends not only on its clinical effectiveness\, but also on demonstrating its value to healthcare decision-makers and ensuring patient access. \nHealth Technology Assessment (HTA) is the process used to evaluate the value of a health intervention or technology and inform reimbursement and healthcare decision-making. \nJoin experts from the Syreon Research Institute for an introduction to HTA and Early HTA\, and learn how these approaches can support the development\, assessment\, and value maximisation of repurposed medicines. \nThe webinar will also explore the role of patient preferences in value assessment\, using case studies to showcase the importance of incorporating patient perspectives to strengthen evidence generation and support patient-centred decision-making. \nRegister for the webinar here!
URL:https://remedi4all.org/event/webinar-understanding-the-value-of-your-repurposed-medicine/
LOCATION:Online Event
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2026/06/CT-Webinar-Series-Webinar-1-FINAL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20260906T140000
DTEND;TZID=Europe/Amsterdam:20260911T170000
DTSTAMP:20260325T092254Z
CREATED:20260225T154749Z
LAST-MODIFIED:20260325T092254Z
UID:17899-1788703200-1789146000@remedi4all.org
SUMMARY:2026 REMEDi4ALL Hackathon
DESCRIPTION:Are you an early career researcher (ECR) who wants to delve into drug repurposing?\n  \nJoin us for the third REMEDi4ALL Hackathon\, 6-11 September 2026\, held at Hotel Checkin Montserrat\, near Barcelona\, Spain. \nThe REMEDi4ALL Repurposing Hackathon is designed to help early career researchers learn by doing. Join a small team of international trainees keen to learn about the repurposing pathway on a week-long residential course where you aim to plan the development of a repurposing candidate for a specific patient community.  \nWho is the Hackathon for?\n\nStudents and researchers in the early stages of their career up to 2 years post-doc\nIndividuals with an interest in drug repurposing\nIndividuals with an excellent scientific track record\nPrevious experience in the drug repurposing field will be considered a plus\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWhat will you learn?\nThe REMEDi4ALL Hackathon aims to teach participants how to: \n\nUse computational tools to generate repurposing candidates suitable for a defined indication\nNarrow down potential repurposed drug options tailored to a particular indication\nIdentify needs and knowledge gaps in a repurposing project\, helping to define the path for a drug candidate\nWork together with other ECRs to complete a repurposing challenge\n\n\n  \n\nTraining format\n\n\n\nIn-person\, residential training for 15 participants\nAdvance registration required\nSmall teams of early career researchers work on a project throughout the week\nSupport through lectures and guidance of REMEDi4ALL experts\, and external advisers\, including patient experts\n\n\n\n\n\n  \nInterested in learning more? Check out our highlights video from 2025 or explore the Hackathon website within the REMEDi4ALL Repurposing Academy.\nApplications open now: apply here
URL:https://remedi4all.org/event/2026-remedi4all-hackathon/
LOCATION:Hotel Checkin Montserrat\, Carrer Querol\, 08293 Collbató\, Barcelona\, Spain
ATTACH;FMTTYPE=image/jpeg:https://remedi4all.org/wp-content/uploads/2025/10/image00005-1-scaled.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20260908T170000
DTEND;TZID=Europe/Amsterdam:20260908T183000
DTSTAMP:20260907T064805Z
CREATED:20260907T064414Z
LAST-MODIFIED:20260907T064805Z
UID:20044-1788886800-1788892200@remedi4all.org
SUMMARY:Improved Patient\, Carer and Clinician Involvement in EU HTA from Hungary
DESCRIPTION:The Hungarian Health Economics Association (META) is pleased to invite patients\, carers\, patient organisation representatives\, clinicians\, HTA professionals and other interested stakeholders to its next online webinar. \nThe participation of Hungarian patients and clinical experts in EU-level Joint Clinical Assessments and Joint Scientific Consultations has so far remained limited\, which may reduce the local relevance and uptake of EU HTA outputs and could also hinder meaningful patient and expert participation in national HTA processes. \nThe presentation section will explain how patients\, carers and clinicians can contribute to EU HTA\, how potential contributors are identified\, and how they can prepare for and improve their chances of being selected for these roles. \nConfirmed speakers: \n\nJulie Spony\, representing the European Commission’s DG SANTE\nJulien Delaye\, Brussels Centre for Collaboration in Health\n\nTheir presentations will be followed by a moderated discussion with participants. \nThe event will also launch a public consultation on a Hungarian-language practical guide being developed by HHEA. The document explains the available opportunities for involvement\, the respective roles and responsibilities\, how potential contributors are identified and selected\, and the key practical considerations for preparing to participate effectively. The guide is so far based on the EU HTA Regulation and related methodological and procedural documentation\, complemented by internationally recognised guidance\, competency frameworks and good practices. The Hungarian community’s contribution would help ensure that\, alongside the relevant European regulatory and methodological requirements\, the guide adequately reflects Hungarian experience and the practical needs of patients\, carers and clinical experts. \nLearn more and register here.
URL:https://remedi4all.org/event/improved-patient-carer-and-clinician-involvement-in-eu-hta-from-hungary/
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2026/09/Hungary.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20261013T160000
DTEND;TZID=Europe/Amsterdam:20261013T170000
DTSTAMP:20260901T134555Z
CREATED:20260901T134555Z
LAST-MODIFIED:20260901T134555Z
UID:19956-1791907200-1791910800@remedi4all.org
SUMMARY:How do you design a clinical study that is registration-ready?
DESCRIPTION:A study that is suitable for publication or guideline development is not automatically suitable for marketing authorisation. Hellen Houlleberghs\, Orfenix’ s clinical director will discuss what changes when the goal is registration of a product instead of just a publication. She will discuss what changes including: study design and endpoints\, study preparation\, CTIS readiness\, GCP\, IMP logistics\, common pitfalls\, timelines\, and post-study obligations. \nParticipants will also receive the “From protocol to registration readiness scan”\, a practical tool to identify potential gaps in their own study. \nVisit the website for more information: https://orfenix.com/webinar-how-do-you-design-a-clinical-study-that-is-registration-ready/ \n Registration link: https://events.teams.microsoft.com/event/b00fe972-6382-435a-8b8c-19b6abf772f0@5b8666c1-d3a4-4d81-841c-691b9585ca11
URL:https://remedi4all.org/event/how-do-you-design-a-clinical-study-that-is-registration-ready/
LOCATION:Webinar
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2026/09/Or_webinar-2-hellen-clinical-featured-image-980x551-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270610
DTEND;VALUE=DATE:20270612
DTSTAMP:20260831T133918Z
CREATED:20260831T133918Z
LAST-MODIFIED:20260831T133918Z
UID:19944-1812585600-1812758399@remedi4all.org
SUMMARY:Repurposing Bootcamp for Patient Representatives
DESCRIPTION:Join the REMEDi4ALL Repurposing Bootcamp and lead the way in innovative treatment strategies.\nThe REMEDi4ALL Repurposing Bootcamp is a specialised training programme designed to empower patient representatives with the essential knowledge and tools to drive innovation through drug repurposing. Our mission is to equip you with the skills and expertise needed to lead efforts in identifying and promoting new therapeutic uses for existing drugs\, ultimately improving access to effective treatments and transforming patient care.  \nOur training programme will offer a comprehensive learning experience through a blend of in-person lectures\, workshops and discussions supported by virtual training materials that will be available soon in our digital academy. Our live programme will cover key aspects of drug repurposing\, including regulatory pathways\, clinical trials\, and patient engagement strategies all curated to ensure maximum relevance to patient group leaders.  \nLearn more here.
URL:https://remedi4all.org/event/repurposing-bootcamp-for-patient-representatives/
LOCATION:Hotel SB BCN Events\, Castelldefels\, Barcelona\, Spain
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2026/08/PatientBootcamp2027.png
END:VEVENT
END:VCALENDAR